As shown in Fig. 6G, increased HSPA4 (P < 0.01), ALKBH5 (P < 0.05) and decreased CD58 (P < 0.05) were observed in tumor tissues of responders compared with non-responders. This evidence concerns the gene CD58 and neoplasm.